Senvest Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Senvest Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$24.48 - $42.47 $19.1 Million - $33.2 Million	-781,325 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $3.25 Million - $4.44 Million	-83,020 Reduced 9.6%	781,325 $32.4 Million
Q2 2020 Aug 13, 2020	SELL	$46.7 - $92.04 $9.99 Million - $19.7 Million	-213,946 Reduced 19.84%	864,345 $41.4 Million
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $6.81 Million - $16.7 Million	-140,830 Reduced 11.55%	1,078,291 $67.9 Million
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $2.77 Million - $5.98 Million	48,211 Added 4.12%	1,219,121 $151 Million
Q3 2019 Nov 13, 2019	BUY	$58.69 - $80.46 $8.48 Million - $11.6 Million	144,522 Added 14.08%	1,170,910 $77.7 Million
Q2 2019 Aug 13, 2019	BUY	$77.77 - $120.68 $28.3 Million - $44 Million	364,188 Added 55.0%	1,026,388 $81.7 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $60.8 Million - $79.9 Million	662,200 New	662,200 $74.1 Million
Q3 2018 Nov 13, 2018	SELL	$88.49 - $127.55 $86.4 Million - $125 Million	-976,127 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$60.0 - $85.67 $10.6 Million - $15.1 Million	-175,905 Reduced 15.27%	976,127 $81.9 Million
Q1 2018 May 14, 2018	BUY	$52.72 - $67.25 $9.55 Million - $12.2 Million	181,106 Added 18.65%	1,152,032 $70.9 Million
Q4 2017 Feb 12, 2018	BUY	$58.2 - $72.76 $22.5 Million - $28.2 Million	387,136 Added 66.31%	970,926 $56.7 Million
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $33.3 Million - $69.3 Million	583,790	583,790 $33.9 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Senvest Management, LLC with notifications on news.